Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Lantern Pharma (LTRN.US)$ Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)
5 MINUTES AGO, 8:00 AM EST
VIA BUSINESSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
476 Views
Comment
Sign in to post a comment